The laboratory calibration references for Ca-P metabolism parameters were as follows: [Ca]alb. (serum), 2.19–2.54 mmol/L; [Ca2+]pH (serum), 1.13–1.32 mmol/L; daily urinary Ca secretion, 2.5–6.25 mmol/24 h (females) and 3.75–7.5 mmol/24 h (males); phosphates (serum), 0.9–1.5 mmol/L; phosphates (urine), 40–136 mg/dL; daily urinary phosphate secretion, 0.4–1.3 g/24 h; PTH (serum), 10–65 pg/mL; and 25(OH)D3, 30–80 ng/mL.
Liaison test
The LIAISON test is a diagnostic laboratory equipment product manufactured by DiaSorin. It is designed to perform immunoassay testing, a technique used for the detection and quantification of specific analytes in a sample. The core function of the LIAISON test is to provide accurate and reliable results for clinical laboratory testing, enabling healthcare professionals to make informed decisions about patient care.
Lab products found in correlation
4 protocols using liaison test
Standardized Biomarker Assessment of Calcium-Phosphate Metabolism
The laboratory calibration references for Ca-P metabolism parameters were as follows: [Ca]alb. (serum), 2.19–2.54 mmol/L; [Ca2+]pH (serum), 1.13–1.32 mmol/L; daily urinary Ca secretion, 2.5–6.25 mmol/24 h (females) and 3.75–7.5 mmol/24 h (males); phosphates (serum), 0.9–1.5 mmol/L; phosphates (urine), 40–136 mg/dL; daily urinary phosphate secretion, 0.4–1.3 g/24 h; PTH (serum), 10–65 pg/mL; and 25(OH)D3, 30–80 ng/mL.
Denosumab's Effects on Bone Metabolism
Venous Blood Sampling and Biochemical Analysis
Bone Mineral Density and Bone Metabolism Markers in Primary Hyperparathyroidism
Venous blood samples were collected after an overnight fasting in all patients. Serum calcium, ionized calcium, phosphate, creatinine, and total alkaline phosphatase were measured according to the routinely used laboratory kits. Serum PTH levels were determined by electrochemiluminescence on an Elecsys 2010 (Roche Diagnostics, Mannheim, Germany), and serum 25-hydroxyvitamin D (25OHD) was measured by a chemiluminescent assay (LIAISON® test, DiaSorin Inc., Stillwater, MN, USA). Plasma IL-17A levels were assayed by Human IL-17 Quantikine ELISA kit (R&D System, Cat. D1700; intra-assay CV 4.7%, interassay CV 8.4%, sensitivity <3.0 pg/ml, by considering an additional point to the low range of the standard curve); plasma OPG was determined by the Human Osteoprotegerin ELISA kit (BioVendor, Cat. RD194003200; intra-assay CV 4.9%, interassay CV 9.0%, sensitivity 0.03 pmol/l) and plasma soluble RANKL by the sRANKL (total) human ELISA kit (BioVendor, Cat. RD193004200R; intra-assay CV 11.5%, inter-assay CV 12.7%, sensitivity 0.4 pmol/l).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!